We are looking to cooperate with experts to be engaged in R&D expert review of VC projects associated with new developments of pharmaceuticals and technologies in the field of medicine.
Cooperation with external experts is subject to a paid basis.
To participate in R&D expert review activities the experts must obtain accreditation (see below).
The work with experts is based on the following:
Accredited experts subject to the expert review shall assess a scientific value of the VC project under review for potential investment pursuant to standard terms of reference. Impersonal consolidated expert report shall be generated following the results of assessment.
For more information concerning R&D expert review process in RusnanoMedInvest, LLC please go here.
Major expert enrollment criteria:
To join our expert team:
The right to verify information provided is vested in RusnanoMedInvest, LLC.
Please note that filled form is not subject to instant accreditation as an expert.
The contract on the expertise is offered by D-Pharma LTD – the management company of RusnanoMedInvest.
Russian pharmaceutical company NovaMedica, a portfolio company of RUSNANO, announces the start of construction of a plant for the production of sterile injectable drugs as part of its long-term strategy to localize innovative medicines and technologies of their development and production in Russia. The plant will be built in the industrial park “Vorsino” in the Kaluga region.
25 July 2017
25 July 2017